The imperial community plays a central role in informing and influencing the G7 summit.
The United Kingdom assumed the presidency of the G7 group of nations in 2021, with the G7 summit scheduled to take place in Carbis Bay, Cornwall, from 11 to 13 June 2021.
Imperial Researchers Help G7 Leaders Make More Informed Decisions on Health Resilience, Sustainable Growth, Disease and Economic Modeling, Antimicrobial Resistance and Artificial Intelligence During Britain’s Group of Democracies Presidency rich.
Resilience Reform Commission
Imperial Oil is one of the advisers and partners of the Resilience Reform Commission, an advisory body of experts and policymakers set up to advise on how we can improve economic and health resilience after COVID-19. Imperial Oil Professor Lord Darzi, Paul Hamlyn Chair of Surgery and Co-Director of the Institute of Global Health Innovation, is one of the commissioners.
Last week, the Commission published its interim report on Healthy Growth, which sets out recommendations for the G7, key lessons from the COVID-19 pandemic and a vision for strengthening health and economic resilience.
The interim report urges G7 leaders to address the following challenges:
- Control the “third wave” of the Delta variant which is now sweeping across South and East Asia.
- Act urgently to tackle global vaccine availability issues; remove barriers to vaccine compliance; and support the appropriate use of vaccine passports, adequate quarantine and better public-private partnerships for disease surveillance and data sharing.
- Important lessons for future pandemic preparedness – too much of the pandemic preparedness program assumes that pandemics are rare.
- The vital longer-term lesson of the coronavirus pandemic as a wake-up call for a serious strengthening of global institutional commitment to economic resilience in health: recognizing that the pace of globalization and climate change is increasing the risk of epidemics of phytosanitary and respiratory diseases.
We have drawn on our expertise across the College to inform these important discussions at the G7 and beyond. Professor Deborah Ashby Imperial College London
Led by Professor Francisco Veloso, Dean of the Business School and Professor Deborah Ashby, Director of the School of Public Health, a team of academics from Imperial submitted evidence to the commission, supported by The Forum, the program political commitment of the Imperial.
Key recommendations from Imperial’s bid were cited in the report, including:
- The need for better integration of macroeconomic models and dynamic models of disease transition
- The need to build on recent experience and find more efficient and faster ways to ensure the implementation of new innovative technologies
- How digital initiatives have helped businesses adapt their businesses during the pandemic and, consequently, how digital capacity can be seen as a mechanism for resilience.
Professor Deborah Ashby said: “Imperial researchers, particularly at the Faculty of Medicine, have played a major role in addressing the challenges presented by the COVID-19 pandemic as it has unfolded. Attention must now also focus on the broader global implications and longer-term resilience, so we have drawn on our expertise across the College to inform these important discussions in the G7 and beyond. “
The final report will be released in November alongside a World Resilience Summit.
Tackling Antimicrobial Resistance
The silent pandemic of antimicrobial resistance (RAM) is on the agenda of the G7 summit. At the summit, G7 health ministers pledged to take strategic action against antimicrobial resistance, alongside global health security, clinical trials and digital health.
Imperial academics are part of an expert panel led by Prof. Alison Holmes that is working on an upcoming review of current evidence and interdisciplinary consensus on key research priorities for optimizing antimicrobial use in human populations, to coincide with and fuel the G7 Summit.
Suboptimal antimicrobial use is a major driver of antimicrobial resistance and poor clinical outcomes. To achieve antimicrobial safety, strategic research priorities have identified the critical need to balance AMR research efforts between the development of new agents and strategies to preserve the efficiency and maximize the efficiency of existing agents. This work identifies research priorities to optimize antimicrobial use and describes actions and strategies to contribute to equitable global health security.
“The global research agenda must also focus on preserving and maximizing the effectiveness of our existing antimicrobials. “ Professor Alison Holmes Imperial College London
Along with this article, this multidisciplinary team of experts led by Imperial with its global partners developed a proposed roadmap for healthcare professionals, policy makers and advocacy groups to address the research priorities identified to optimize the use of antimicrobials in humans. It recommends that in order to close the gaps in antimicrobial resistance and achieve antimicrobial safety, research should focus on building capacity to conduct equitable research on four distinct research themes: policy and strategic planning, management. drugs and prescription systems, technological innovation and context, culture and behavioral research.
Professor Alison Holmes said: “There has been significant research investment in the development of new antimicrobials to treat drug-resistant infections. However, as the world awaits new agents, the global research agenda must also focus on preserving and maximizing the effectiveness of our antimicrobials. “
Esmita Charani, Senior Research Pharmacist, Department of Infectious Diseases, and one of the authors, said: “Antimicrobial resistance is a global threat that can only be tackled through collaboration and partnerships spanning different economies, sectors and health care populations.
“Working with expert colleagues around the world, including patient and public advocates, we have identified key research priorities that must be addressed if we are to optimize the use of existing and emerging antibiotics. The next steps are to act on this work and address these identified research needs by building on our existing global research partnerships and collaboration between different health economies and populations. ”
The next steps are to follow up on this work and address these identified research needs by building on our existing global research partnerships and collaboration between different health economies and populations. Dr Esmita Charani Imperial College London
Imperial is also contributing its expertise through an upcoming article on innovation and technology to support optimized antimicrobial use and accurate prescribing.
It will review cutting-edge technologies under development that have the potential to overcome current barriers and support wider implementation of precision antimicrobial dosing. This includes Imperial research from the Center for Antimicrobial Optimization (CAMO) into real-time therapeutic drug monitoring based on biosensors, closed-loop control systems, and artificial intelligence-based decision support tools.
Dr Timothy Miles Rawson, Honorary Clinical Investigator in the Department of Infectious Diseases, said: “Optimizing the use of antimicrobials is important to ensure the best outcomes for our infected patients, while minimizing the development of drug resistance. . Our review explores the state of the art in this area, much of which has been developed through collaboration between departments at Imperial College London working within the Center for Antimicrobial Optimization.
Alliance U7 +
the Alliance U7 + universities, including Imperial, called on the G7 to recognize the key role universities play as leading global players and wishes to highlight priority areas in terms of opportunities to collaborate with G7 leaders to actively take responsibility and foster intergenerational dialogue on issues important for this year’s multilateral agenda:
- Leading the global recovery of the coronavirus while building resilience in the face of future pandemics: resilience depends on the education of our citizens, and U7 + recognizes the distinctive responsibility of our universities to train and nurture responsible and active citizens who will contribute to society at all levels.
- Fight against climate change and preserve the planet’s biodiversity: Universities have a major role to play in solving environmental problems and are committed to promoting access to courses related to climate, biodiversity and sustainability for all students. We have started an intergenerational dialogue on climate change and environmental degradation and are actively working to reduce our greenhouse gas emissions.
- Defend shared global values: U7 + encourages G7 leaders to actively foster intergenerational dialogue on issues of inclusion and equality, such as the global gender pay gap. U7 + calls on the G7 to promote pathways to higher education for young people from marginalized backgrounds and insists that freedom of expression and open dialogue are essential for a well-functioning democracy.
The U7 + Alliance spans six continents and represents all G7 nations as well as 10 other nations. It’s the first alliance of university presidents aiming to structure and advance their role as global actors through the multilateral agenda.